Robert Lewis
President and Chief Executive Officer at Nok Therapeutics. Executive Officer, Director and Promoter at Jabez Biosciences.
Earliest Form D on file: Mar 2026
7 filings at 2 companies
Biotech, Cranberry Twp. PA
President and Chief Executive Officer · signer
Biotech, Cranberry Twp. PA
Executive Officer, Director, Promoter
- Signed
- Named
- AmendmentAmendment of an earlier filing
- Size is amount sold, up to $30M
Filings
7 filings · 4 offerings- Apr 22, 2026Amendment
Nok Therapeutics, signed · Form D
$751K
Apr 22, 2026AmendmentLatest May 1, 2026
Signed as President and Chief Executive Officer
$751K
—
- Apr 22, 2026Amendment
Nok Therapeutics, signed · Form D
$649K
of $750K
Apr 22, 2026AmendmentSigned as President and Chief Executive Officer
$649K
$750K
- Mar 26, 2026
Jabez Biosciences, named · Form D
$31K
- Mar 26, 2026
Nok Therapeutics, signed · Form D
$3K
of $3K
Mar 26, 2026Latest May 1, 2026
Signed as President and Chief Executive Officer
$3K
$3K
Network
Also at Jabez Biosciences and Nok Therapeutics
5 peopleExecutive Officer, Director at both
Director at both
Promoter at both
Director at both
Promoter at both
Only at Jabez Biosciences
1 personExecutive Officer, Director, Promoter, signed as President and Chief Executive Officer